Cell Transplantation for Patients with Parkinson's Disease
This chapter focuses on cell replacement therapies in Parkinson’s disease (PD) and describes experimental data leading to clinical trials, aswell as the methodology and efficacy of grafts of human embryonic nigral tissue in patients with PD. It also highl
- PDF / 19,676,873 Bytes
- 415 Pages / 439.37 x 666.142 pts Page_size
- 115 Downloads / 239 Views
Volume 174
Editor-in-Chief F. Hofmann, München Editorial Board J. Beavo, Seattle, WA D. Ganten, Berlin M. Michel, Amsterdam C. Page, London W. Rosenthal, Berlin
Anna M. Wobus
•
Kenneth R. Boheler
Editors
Stem Cells Contributors M.R. Alison, C. Badorff, N. Benvenisty, B. Berninger, N. Beyer Nardi, A. Branzi, M. Brittan, P. Budde, G.A. Colvin, H. Darr, C. Denning, S. Dimmeler, F. Dönmez, M.S. Dooner, R. Enseñat-Waser, L.J. Field, M. Götz, G. Grenier, M. Hack, R. Harris, J. Jones, T. León-Quinto, M. Lovell, C. Mummery, R. Passier, G. Paul, P.J. Quesenberry, J.A. Reig, E. Roche, S. Rose-John, M. Rubart, M.A. Rudnicki, H. Sauer, L. da Silva Meirelles, B. Soria, N.D. Theise, C. Ventura, M. Wartenberg, G. Weitzer, N.A. Wright
123
Professor Anna M. Wobus, PhD In Vitro Differentiation Group Dept. of Cytogenetics Leibnitz Institute of Plant Genetics and Crop Plant Research (IPK) Corrensstr. 3 D-06466 Gatersleben Germany [email protected]
Kenneth R. Boheler, PhD Investigator Laboratory of Cardiovascular Science Gerontology Research Program National Institute on Aging, NIH 5600 Nathan Shock Drive Baltimore, MD 21224 USA [email protected]
ISBN: 978-3-540-77854-7 Handbook of Experimental Pharmacology ISSN 0171-2004 Library of Congress Control Number: 2008920054 c Springer-Verlag Berlin Heidelberg 2008
This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilm or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permitted only under the provisions of the German Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Springer. Violations are liable to prosecution under the German Copyright Law. The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. Product liability: The publisher cannot guarantee the accuracy of any information about dosage and application contained in this book. In every individual case the user must check such information by consulting the relevant literature. Cover Design: WMXDesign GmbH, Heidelberg Printed on acid-free paper 9 8 7 6 5 4 3 2 1 springer.com
Preface
Significant advances in stem cell research and their potentials for therapeutic applications have attracted the attention of the scientific community and captured the imagination of society as a whole. Not so long ago, the study of most stem cells, other than those that regenerated the haematopoietic system, was rather obscure and limited to a relatively small number of researchers and laboratories. The uproar over stem cells really began in 1998 with the successful derivation of pluripotent human embryonic stem (ES) cells by James
Data Loading...
